RTX Corp. (RTX.US), the largest U.S. defense prime and formerly Raytheon, delivered better than expected results for Q4 2025 and confirmed that momentum is carrying into 2026. Both revenue and earnings per share beat Wall Street estimates, reinforcing the broader uptrend across the defense space. The company’s most important long-term growth catalyst appears to be the “Golden Dome” program, although uncertainty around its execution, including political friction with Canada and discussions involving Greenland, may delay any valuation premium tied to potential profits from the project. RTX has also recently been singled out by Trump, who described the company as the least willing to align with new White House guidance. That guidance is increasing pressure on defense contractors to invest more aggressively in domestic factories and ramp production capacity as quickly as possible.
RTX Q4 2025 results
-
Revenue: $24.2B, up 12% YoY and clearly above market expectations (around $22.7B).
-
Adjusted EPS: $1.55, above consensus (around $1.47).
-
YoY EPS growth: +1%, suggesting the quarter was more volume-driven than margin-driven.
-
Cash generation: Free cash flow of $3.2B and operating cash flow of $4.2B were among the strongest highlights of the report.
Importantly, all key segments contributed to the quarter:
-
Collins Aerospace
-
Pratt & Whitney
-
Raytheon
GAAP EPS of $1.19 was weighed down by acquisition accounting and restructuring items. For the market, the backlog remains the core pillar of the story: RTX reported a $268B order backlog, including $161B in commercial and $107B directly tied to defense.
Full-year 2025 snapshot
The sharp improvement in free cash flow indicates RTX is moving beyond the “operational cleanup” phase seen in prior years:
-
Revenue: $88.6B (+10% YoY).
-
Adjusted EPS: $6.29 (+10% YoY).
-
Free cash flow: $7.9B, up $3.4B YoY.
2026 outlook
The 2026 guidance looks conservative but highly credible, with room for potential upgrades:
-
Revenue: $92–$93B (5%–6% organic growth).
-
Adjusted EPS: $6.60–$6.80.
-
Free cash flow: $8.25–$8.75B.
The gap between revenue growth (+12%) and adjusted EPS growth (+1%) in Q4 points to cost pressure and or capacity investment. In 2026, the market will be watching operating leverage closely. Overall, RTX enters 2026 with momentum, a large backlog, and improving cash flow, but the key story for the coming quarters will be margins and execution, not order intake alone.

Source: xStation5
Daily summary: Wall Street and EURUSD rise ahead of tomorrowโs Fed decision ๐ฝ Oil gains
Tesla Ahead of Earnings: Moderate Expectations and Weak Fundamentals
ASML: Will Europeโs technology hegemon beat expectations once again?
US Open: US500 near record highs ๐ UnitedHealth shares crash 17%, Micron and RTX Corp gain
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.